Fundraising Fox

Riskgaming

Hayward, US · Founded 2019 · 5 known investors

Riskgaming creates immersive strategy simulation games where high-level decision-makers assume roles and navigate complex scenarios involving technology, business, and geopolitical challenges to explore alternative outcomes and inform real-world decisions.

Biotech

Founders & leadership

Riskgaming was founded in 2019 by Kegan Schouwenburg.

KS
Kegan SchouwenburgFounder
RMRoger M. Perlmutter
Roger M. PerlmutterinExecutiveExecutive Officer, Director at Eikon Therapeutics

Board

JWJoshua Wolfe
Joshua Wolfein𝕏Board directorPartner and Co-Founder at Lux Capital
DB
Dror BermanBoard director
JT
James TananbaumBoard director
LC
Leon ChenBoard director
AGAdam Goulburn
Adam Goulburnin𝕏Board directorFounder and Managing Partner at Dimension Capital
ZSZack Schildhorn
Zack Schildhornin𝕏Board directorVenture Partner at Lux Capital
RH
Robbie HuffinesBoard director
KF
Kenneth FrazierBoard director
RW
Robin WashingtonBoard director
TU
Terdema UsseryBoard director

Investors · 5

Bain Capital Life SciencesBoston
Cisco InvestmentsSan Jose
Foresite CapitalWest Hollywood
Lux CapitalNew York · $100K – $100M
Dimension CapitalreportedSan Francisco · $1M – $10M

Funding

SEC filings, press & company announcements

$1.1B disclosed across 6 of 7 rounds · 2014–2026

▶$350.7MraisedFeb 2025 · 27 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robbie HuffinesDirector
  • Joshua WolfeDirector
  • Dror BermanDirector
  • James TananbaumDirector
  • Leon ChenDirector
  • Kenneth FrazierDirector
  • Robin WashingtonDirector
  • Roger M. PerlmutterExecutive Officer, Director
Offering amount
$400M
Amount sold
$350.7M
First sale
Feb 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$140.8MraisedJun 2023 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robin WashingtonDirector
  • Dan AndersonExecutive Officer
  • Ashish KheterpalExecutive Officer
  • Kenneth FrazierDirector
  • Josh WolfeDirector
  • Dror BermanDirector
  • Russ BermanExecutive Officer
  • Leon ChenDirector
  • James TananbaumDirector
  • Roy BanesExecutive Officer
  • Roger M. PerlmutterExecutive Officer, Director
  • Benjamin ThornerExecutive Officer
  • Alfred BowieExecutive Officer
  • Barbara HowesExecutive Officer
Offering amount
$535M
Amount sold
$140.8M
Minimum investment
$33.7K
First sale
May 2023
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$517.8MraisedJan 2022 · 43 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alfred BowieExecutive Officer
  • Roger M. PerlmutterExecutive Officer, Director
  • Adam GoulburnDirector
  • James TananbaumDirector
  • Leon ChenDirector
  • Benjamin ThornerExecutive Officer
  • Dror BermanDirector
Offering amount
$525M
Amount sold
$517.8M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$102.5MraisedMay 2021 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James TananbaumDirector
  • Leon ChenExecutive Officer, Director
  • Adam GoulburnDirector
  • Roger M PerlmutterExecutive Officer, Director
  • Dror BermanDirector
Offering amount
$107.8M
Amount sold
$102.5M
First sale
May 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.4MraisedFeb 2016 · 12 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kegan SchouwenburgExecutive Officer, Director
  • Zack SchildhornDirector
  • Terdema UsseryDirector
Offering amount
$7M
Amount sold
$4.4M
First sale
Feb 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedApr 2014 · 4 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Zack SchildhornDirector
  • Kegan SchouwenburgExecutive Officer, Director
Offering amount
$6M
Amount sold
$6M
First sale
Mar 2014
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Riskgaming went on to found or lead other companies.

Josh WolfeDirectorFounded Genocea BiosciencesAdam GoulburnDirectorFounded Kallyope

In the news

FMR LLC Expands Eikon Therapeutics Inc (EIKN) Stake Despite Post-IPO Slidegurufocus.com · Aug 2026Iran, data centers, Victorian AI - by Danny Crichtonblog.riskgaming.com · Apr 2026Perlmutter-backed Eikon Therapeutics raises $381.2 million in IPO | Reutersreuters.com · Feb 2026Eikon sets $274M goal for upcoming stock market debutfiercebiotech.com · Jan 2026VC 101: the denominator effect - Riskgaming by Lux Capitalblog.riskgaming.com · Aug 2022Sols Systems walks away with funding -globalventuring.com · Apr 2014

Frequently asked questions

What does Riskgaming do?
Riskgaming creates immersive strategy simulation games where high-level decision-makers assume roles and navigate complex scenarios involving technology, business, and geopolitical challenges to explore alternative outcomes and inform real-world decisions.
Who founded Riskgaming?
Riskgaming was founded by Kegan Schouwenburg in 2019.
Who are Riskgaming's investors?
Riskgaming's investors include Bain Capital Life Sciences, Cisco Investments, Foresite Capital, Lux Capital, Dimension Capital.
How much funding has Riskgaming raised?
Riskgaming has disclosed $1.1B raised across 6 of its 7 known rounds.
Where is Riskgaming headquartered?
Riskgaming is headquartered in Hayward, US.